| Market Cap | €20.4M | |
| Enterprise Value | — | |
| Revenue | €4.1M | −46.9% |
| Gross Profit | €536,000 | −70.5% |
| EBITDA | — | — |
| Net Income | -€14.1M | — |
| Diluted EPS | -€0.32 | — |
| Free Cash Flow | — | — |
| Ratio | 2020 | 2021 | 2022 | 2023 | Trend · 4y | vs own |
|---|---|---|---|---|---|---|
| ▾Margins | ||||||
| Gross Margin | 49.48% | 35.12% | 23.76% | 13.21% | 13% | |
| Operating Margin | −280.27% | −103.70% | −118.07% | −290.98% | 13% | |
| Net Margin | −311.93% | −121.30% | −129.11% | −348.64% | 13% | |
| OCF Margin | −379.50% | −130.92% | −107.37% | −213.45% | 38% | |
| Gross Profitability | 2.60% | 3.26% | 3.16% | 1.07% | 13% | |
| ▸Returns on Capital · 3 ratios | ||||||
| ▸DuPont factors (ROE drivers) · 2 ratios | ||||||
| ▸Earnings quality · 1 ratios | ||||||
| ▸Liquidity & coverage · 3 ratios | ||||||
| ▸Working capital · 8 ratios | ||||||
| ▸Other · 1 ratios | ||||||
| Line | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| Revenue | €2.2M | €5.6M | €7.6M | €4.1M |
| YoY % | +156.1% | +35.4% | -46.9% | |
| Cost of Revenue | €1.1M | €3.7M | €5.8M | €3.5M |
| YoY % | +228.9% | +59.1% | -39.6% | |
| R&D Expense | €5.8M | €4.7M | €4.8M | €4.4M |
| YoY % | -19.6% | +2.7% | -7.5% | |
| Operating Income | -€6.2M | -€5.9M | -€9.0M | -€11.8M |
| Equity Method Income | — | -€321,000 | -€459,000 | -€875,000 |
| Income Tax | €0 | €0 | €0 | €0 |
| Net Income (incl. NCI) | -€6.9M | -€6.8M | -€9.9M | -€14.1M |
| Minority Interest (P&L) | €0 | €0 | €0 | €0 |
| Net Income | -€6.9M | -€6.8M | -€9.9M | -€14.1M |
| EPS (Basic) | -€0.32 | -€0.19 | -€0.24 | -€0.32 |
| EPS (Diluted) | -€0.32 | -€0.19 | -€0.24 | -€0.32 |
Statement lines are XBRL facts as filed with the company's home regulator (SEC EDGAR for US filers; ESEF/EDINET and other national regulators for foreign filers); ratios and other derived figures are computed from them. A blank cell means the tag was absent — never imputed.
